PCI Biotech to present at DNB Markets' Nordic Health Care Conference 2012
December 06, 2012 02:00 ET
|
PCI Biotech Holding ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Oslo, 6 December 2012 - PCI Biotech (PCIB) will...
PCI Biotech skal presentere på DNB Markets Nordic Health Care Conference 2012
December 06, 2012 02:00 ET
|
PCI Biotech Holding ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Oslo, 6.desember 2012 - PCI Biotech (PCIB) skal...
PCI Biotech: Market Maker Agreement
November 13, 2012 02:45 ET
|
PCI Biotech Holding ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Oslo, 13 November 2012 - PCI Biotech (PCIB) has...
PCI Biotech: Markedspleieavtale
November 13, 2012 02:45 ET
|
PCI Biotech Holding ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Oslo, 13.november 2012 - PCI Biotech (PCIB) har...
PCI Biotech: Financial calendar 2013
October 30, 2012 03:15 ET
|
PCI Biotech Holding ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} 5 February 2013 - Presentation of the fourth...
PCI Biotech: Finansiell kalender 2013
October 30, 2012 03:15 ET
|
PCI Biotech Holding ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} 5.februar 2013 - Presentasjon av rapport for 4.kvartal...
PCI Biotech: Third quarter 2012 report
October 30, 2012 03:00 ET
|
PCI Biotech Holding ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Oslo, Norway, 30 October 2012.Please find attached...
PCI Biotech: Resultatrapport for 3.kvartal 2012
October 30, 2012 03:00 ET
|
PCI Biotech Holding ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Oslo, 30.oktober 2012Vedlagt er rapport for tredje...
PCI Biotech: Results from the first clinical study of Amphinex to be presented at the ESMO 2012 Congress in Vienna
September 24, 2012 09:00 ET
|
PCI Biotech Holding ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Oslo, 24 September 2012 - PCI Biotech (PCIB) the...
PCI Biotech: Results from the first clinical study of Amphinex to be presented at the ESMO 2012 Congress in Vienna
September 24, 2012 09:00 ET
|
PCI Biotech Holding ASA
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Oslo, 24 September 2012 - PCI Biotech (PCIB) the...